Comparison of different routes of administration of nadroparin in hemodialysis

Clinical Nephrology

Volumn 52, Issue 5, 1999, Pages 322-325

  Vanuytsel, J L ^a   Lins, R L ^a,b   Zachee P ^a   Mattheeussen, J ^a   Hosten, S ^a   Lens, S ^a   Daelemans, R ^a  

^a Stuivenberg General Hospital   (Belgium)

^b AZ Stuivenberg ^*  (Belgium)

Author keywords

Efficacy; Hemodialysis; Low molecular weight heparin nadroparin; Route of administration; Safety

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICOAGULANTS; CREATININE; CROSS-OVER STUDIES; FACTOR XA; FEMALE; HEMOGLOBINS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NADROPARIN; RENAL DIALYSIS; UREA;

EID: 0032740733     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Anastassiades E, Ireland H, Flynn A, Lane DA, Curtis JR 1990 A low molecular weight heparin (Fragmin) in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin. Nephrol Dial Transplant 5: 135-140
2. Lindsay RM, Smith AM 1989 Practical use of anticoagulant. In: Maher J (ed) Replacement of Renal Function by Dialysis. Kluwer, Dordrecht, pp 246-275
3. Ljungberg B 1985 A low molecular heparin fraction as an anticoagulant during hemodialysis. Clin Nephrol 24: 15-20
4. Marinière P, Dieval J, Bayrou B, Roussel B, Renaud H, Fournier A, Delobel J 1989 Low molecular weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study. Blood Purif 7: 301-308
5. Nurmohamed MT, Ten Cate J, Stevens P, Hoek JA, Lins RL, Ten Cate J-W 1989 Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin. ASAIO Trans 37: M459-M461
6. Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F 1989 Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int 33: 890-896
7. Suzuki T, Ota K, Naganuma S, Koshikawa S, Hirasawa Y, Nakagawa S, Otsuho O, Akizawa T 1990 Clinical application of Fragmin in hemodialysis: multicenter cooperative study in Japan. Semin Thromb Haemostas 16: S46-S54